During the past decade, Praxis am Evangelischen Krankenhaus Bethanien conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Praxis am Evangelischen Krankenhaus Bethanien" are "Chronic Lymphocytic Leukemia" (1 trials), "Leukemia" (1 trials) and "Neuroblastoma" (1 trials). Many other conditions were trialed in "Praxis am Evangelischen Krankenhaus Bethanien" in a lesser frequency.

Most popular intervention types in "Praxis am Evangelischen Krankenhaus Bethanien" are "Drug" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "etoposide" (2 trials), "filgrastim" (2 trials), "peripheral blood stem cell transplantation" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Praxis am Evangelischen Krankenhaus Bethanien" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Praxis am Evangelischen Krankenhaus Bethanien". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Praxis am Evangelischen Krankenhaus Bethanien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis am Evangelischen Krankenhaus Bethanien, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".